Connection

Robert Leman to Aged

Back to Details
This is a "connection" page, showing publications Robert Leman has written about Aged.
Robert Leman
Connection Strength
0.175
Aged
  1. Treatment of coronary artery disease in hemodialysis patients: PTCA vs. stent. Catheter Cardiovasc Interv. 2001 Dec; 54(4):459-63.
    View in: PubMed
    Score: 0.016
  2. Significant complications can occur with ischemic heart disease and tilt table testing. Pacing Clin Electrophysiol. 1999 Apr; 22(4 Pt 1):675-7.
    View in: PubMed
    Score: 0.013
  3. The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2016 Aug; 39(8):863-9.
    View in: PubMed
    Score: 0.011
  4. The impact of device recall on patients and family members of patients with automatic implantable cardioverter defibrillators. Heart Lung. 1994 Jul-Aug; 23(4):317-22.
    View in: PubMed
    Score: 0.010
  5. The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jun; 25(6):624-30.
    View in: PubMed
    Score: 0.009
  6. Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol. 2013 Apr 15; 111(8):1165-8.
    View in: PubMed
    Score: 0.009
  7. A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy. Heart Rhythm. 2011 May; 8(5):685-91.
    View in: PubMed
    Score: 0.008
  8. Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract. Heart Rhythm. 2010 Nov; 7(11):1561-6.
    View in: PubMed
    Score: 0.007
  9. Interventional treatment for ventricular arrhythmias: the initial South Carolina case. J S C Med Assoc. 1990 Jun; 86(6):341-5.
    View in: PubMed
    Score: 0.007
  10. The potential utility of sensor-driven pacing in DDD pacemakers. Am Heart J. 1989 Nov; 118(5 Pt 1):919-23.
    View in: PubMed
    Score: 0.007
  11. Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009 Nov 01; 104(9):1256-8.
    View in: PubMed
    Score: 0.007
  12. Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2009 Aug; 20(8):894-900.
    View in: PubMed
    Score: 0.007
  13. Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):383-90.
    View in: PubMed
    Score: 0.007
  14. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
    View in: PubMed
    Score: 0.007
  15. Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm. 2008 Mar; 5(3):394-9.
    View in: PubMed
    Score: 0.006
  16. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2007 May; 18(5):490-6.
    View in: PubMed
    Score: 0.006
  17. Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. J Natl Med Assoc. 2006 Mar; 98(3):330-9.
    View in: PubMed
    Score: 0.005
  18. Radionuclide evaluation of dual chamber pacing: comparison between variable AV intervals and ventricular pacing. Pacing Clin Electrophysiol. 1985 May; 8(3 Pt 1):408-14.
    View in: PubMed
    Score: 0.005
  19. Relation of initial resting ventricular rate to the ability to achieve and maintain normal sinus rhythm in patients with atrial fibrillation. Am J Cardiol. 2005 Mar 01; 95(5):597-602.
    View in: PubMed
    Score: 0.005
  20. Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies. Am J Cardiol. 2004 Dec 15; 94(12):1572-4.
    View in: PubMed
    Score: 0.005
  21. Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):144-9.
    View in: PubMed
    Score: 0.004
  22. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. Pacing Clin Electrophysiol. 2003 Jan; 26(1P2):483-6.
    View in: PubMed
    Score: 0.004
  23. Single- versus dual-chamber sensor-driven pacing: comparison of cardiac outputs. Am Heart J. 1991 Sep; 122(3 Pt 1):728-32.
    View in: PubMed
    Score: 0.002
  24. Pacemaker follow-up and adequacy of Medicare guidelines. Am Heart J. 1988 Jul; 116(1 Pt 1):11-5.
    View in: PubMed
    Score: 0.002
  25. Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial. Am J Cardiol. 1987 Dec 14; 60(17):29I-35I.
    View in: PubMed
    Score: 0.002
  26. Limitations of the long-term clinical application of rate hysteresis. Pacing Clin Electrophysiol. 1987 Mar; 10(2):302-4.
    View in: PubMed
    Score: 0.001
  27. An argument for pacemaker reuse: pacemaker mortality in 169 patients over ten years. Pacing Clin Electrophysiol. 1986 Nov; 9(6 Pt 2):1295-8.
    View in: PubMed
    Score: 0.001
  28. Steroid treatment of the painful pacemaker pocket. Pacing Clin Electrophysiol. 1984 Jan; 7(1):71-3.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.